This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Physician perspectives on Visby’s FDA-authorized at-home PCR STI test within current STI testing and diagnostic workflows

Ticker(s): VISBY MEDICAL, LH, DGX

Who's the expert?

Institution: University of Texas Houston Medical Center

  • Board certified female pelvic medicine and reconstructive surgery and obstetrics and gynecology.
  • Currenty treats over 250 patients per year for uUTIs and manages 60 patients for postpartum depression
  • Primary clinical interests are pelvic floor disorders, urinary incontinence and pelvic organ prolapse.

Interview Questions
Q1.

Please briefly describe your specialty, practice setting, and patient population?

Added By: dami_admin
Q2.

Approximately how frequently do you diagnose or manage patients with sexually transmitted infections?

Added By: dami_admin
Q3.

How are STIs typically diagnosed in your practice today? Do you think at-home PCR diagnostics will become more common in infectious disease testing?

Added By: dami_admin

Are You Interested In These Questions?

Slingshot Insights Explained
1Day Left to Join Project
Call Date
Mar 11, 2026
Call Time
02:00 PM EDT
Wall Street Time

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.